Ultrasound Int Open 2016; 02(02): E58-E62
DOI: 10.1055/s-0042-106397
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Assessment of Midfacial Hypoplasia in Down Syndrome Fetuses – Validity of a Two-Line Approach and Introduction of a Novel Angle (Maxilla-Mandible-Nasion Angle)

J. Weichert
1   Prenatal Medicine, University Hospital of Schleswig-Holstein, Luebeck, Germany
,
M. Gembicki
1   Prenatal Medicine, University Hospital of Schleswig-Holstein, Luebeck, Germany
,
J. Ribbat-Idel
2   Department of Pathology, University Hospital of Schleswig-Holstein, Luebeck, Germany
,
D. R. Hartge
1   Prenatal Medicine, University Hospital of Schleswig-Holstein, Luebeck, Germany
› Author Affiliations
Further Information

Publication History

received 04 August 2015

accepted 22 March 2016

Publication Date:
20 June 2016 (online)

Abstract

Purpose:

To scrutinize the validity of a novel angle (maxilla-mandible-nasion angle, MMN) as objective proof of midfacial hypoplasia in trisomy 21 fetuses.

Materials and Methods:

Volume data sets of 2nd trimester fetuses were reviewed in this retrospective study. After achievement of the correct midsagittal position, the fetal profile line (FP line) and the mandibulo-maxillary line (MML) were applied and the resulting angle was calculated. Additionally, the prefrontal space ratio (PFSR) was assessed. Both measurements were obtained from 401 euploid fetuses and 42 fetuses with trisomy 21. Values for MMN and PFSR<5th percentile were considered abnormal.

Results:

The study included 443 fetuses with a mean gestational age of 21.3 weeks (range: 14.0–26.3). The MMN angle sufficiently identified hypoplasia of the midface in trisomy 21 fetuses (mean: 14.6°; range: 10.1°− 22.0°) compared to controls (mean: 20.5°; range: 17.3°–23.7°; p<0.0001). Concomitantly, the PFSR of Down syndrome fetuses was significantly lower (mean: 0.53; range: 0.21–1.22) than in euploid individuals (1.38; range: 0.54–2.23; p<0.0001).

Conclusion:

Calculation of the novel MMN angle in 2nd trimester fetuses reliably allows rapid assessment of craniofacial anatomy in order to rule out the midfacial hypoplasia frequently found in trisomy 21.

 
  • References

  • 1 Westerman GH, Johnson R, Cohen MM. Variations of palatal dimensions in patients with Down's syndrome. J Dent Res 1975; 54: 767-771
  • 2 Dagklis T, Borenstein M, Peralta CF et al. Three-dimensional evaluation of mid-facial hypoplasia in fetuses with trisomy 21 at 11+0 to 13+6 weeks of gestation. Ultrasound Obstet Gynecol 2006; 28: 261-265
  • 3 Alió J, Lorenzo J, Iglesias MC et al. Longitudinal maxillary growth in Down syndrome patients. Angle Orthod 2011; 81: 253-259
  • 4 Mihailovic T, Stimec BV, Terzic M et al. The absence of the vomer in the first and early second trimester of pregnancy – a new marker of trisomy 21 and trisomy 13. Ultraschall Med 2012; 33: E68-E74
  • 5 Andersson EM, Axelsson S, Austeng ME et al. Bilateral hypodontia is more common than unilateral hypodontia in children with Down syndrome: a prospective population-based study. Eur J Orthod 2014; 36: 414-418
  • 6 Allanson JE, O'Hara P, Farkas LG et al. Anthropometric craniofacial pattern profiles in Down syndrome. Am J Med Genet 1993; 47: 748-752
  • 7 Farkas LG, Katic MJ, Forrest CR et al. Surface anatomy of the face in Down’s syndrome: linear and angular measurements in the craniofacial regions. J Craniofac Surg 2001; 12: 373-379
  • 8 Sonek J, Borenstein M, Dagklis T et al. Frontomaxillary facial angle in fetuses with trisomy 21 at 11–13(6) weeks. Am J Obstet Gynecol 2007; 196: e1-e4
  • 9 Molina F, Persico N, Borenstein M et al. Frontomaxillary facial angle in trisomy 21 fetuses at 16–24 weeks of gestation. Ultrasound Obstet Gynecol 2008; 31: 384-387
  • 10 Sonek J, Molina F, Hiett AK et al. Prefrontal space ratio: comparison between trisomy 21 and euploid fetuses in the second trimester. Ultrasound Obstet Gynecol 2012; 4: 293-296
  • 11 de Jong-Pleij EA, Ribbert LS, Pistorius LR et al. The fetal profile line: a proposal for a sonographic reference line to classify forehead and mandible anomalies in the second and third trimester. Prenat Diagn 2012; 32: 797-802
  • 12 Ferrario VF, Dellavia C, Zanotti G et al. Soft tissue facial anthropometry in Down syndrome subjects. J Craniofac Surg 2004; 15: 528-532
  • 13 Suri S, Tompson BD, Cornfoot L. Cranial base, maxillary and mandibular morphology in Down syndrome. Angle Orthod 2010; 80: 861-869
  • 14 Cicero S, Curcio P, Rembouskos G et al. Maxillary length at 11-14 weeks of gestation in fetuses with trisomy 21. Ultrasound Obstet Gynecol 2004; 24: 19-22
  • 15 Sforza C, Dellavia C, Dolci C et al. A quantitative three-dimensional assessment of abnormal variations in the facial soft tissues of individuals with Down syndrome. Cleft Palate Craniofac J 2005; 42: 410-416
  • 16 Persico N, Borenstein M, Molina F et al. Prenasal thickness in trisomy-21 fetuses at 16–24 weeks of gestation. Ultrasound Obstet Gynecol 2008; 32: 751-754
  • 17 de Jong-Pleij EA, Vos FI, Ribbert LS et al. Prenasal thickness-to-nasal bone length ratio: a strong and simple second- and third-trimester marker for trisomy 21. Ultrasound Obstet Gynecol 2012; 39: 185-190
  • 18 Vos FI, De Jong-Pleij EA, Bakker M et al. Trends in serial measurements of ultrasound markers in second and third trimester Down syndrome fetuses. Fetal Diagn Ther 2015; Jan 30. [Epub ahead of print]
  • 19 Gonzalez R, Aedo S, Dezerega V et al. Frontonasal fold thickness-to-nasal bone length ratio as a prenatal sonographic marker for trisomy 21 in a low-risk population. J Ultrasound Med 2013; 32: 795-800
  • 20 Yazdi B, Sonek J, Oettling C et al. Prefrontal space ratio in second- and third-trimester screening for trisomy 21. Ultrasound Obstet Gynecol 2013; 41: 262-266
  • 21 Chaveeva P, Agathokleous M, Poon LC et al. Second-trimester screening for trisomy-21 using prefrontal space ratio. Fetal Diagn Ther 2013; 34: 50-55
  • 22 Vos FI, de Jong-Pleij EA, Bakker M et al. Nasal bone length, prenasal thickness, prenasal thickness to nasal bone length ratio and the prefrontal space ratio in second and third trimester Down syndrome. Ultrasound Obstet Gynecol 2014; Apr 21 DOI: 10.1002/uog.13391. [Epub ahead of print]
  • 23 Yazdi B, Riefler P, Fischmüller K et al. The frontal space measurement in euploid and aneuploid pregnancies at 11–13 weeks’ gestation. Prenat Diagn 2013; 33: 1124-1130
  • 24 de Jong-Pleij EA, Ribbert LS, Manten GT et al. Maxilla-nasion-mandible angle: a new method to assess profile anomalies in pregnancy. Ultrasound Obstet Gynecol 2011; 37: 562-569
  • 25 Alphonse J, Cox J, Clarke J et al. Comparison of frontomaxillary facial angles using both 2D and 3D ultrasound at 11+0 to 13+6 weeks of gestation. Fetal Diagn Ther 2010; 28: 14-21
  • 26 de Jong-Pleij EA, Ribbert LS, Tromp E et al. Three-dimensional multiplanar ultrasound is a valuable tool in the study of the fetal profile in the second trimester of pregnancy. Ultrasound Obstet Gynecol 2010; 35: 195-200
  • 27 Ramos GA, Kfir M, Lee S et al. Benefits of a systematic approach in the evaluation of fetal facial 3-dimensional volumes. J Ultrasound Med 2011; 30: 473-479
  • 28 Vos FI, de Jong-Pleij EA, Ribbert LS et al. Three-dimensional ultrasound imaging and measurement of nasal bone length, prenasal thickness and frontomaxillary facial angle in normal second- and third-trimester fetuses. Ultrasound Obstet Gynecol 2012; 39: 636-641
  • 29 Vos FI, Bakker M, de Jong-Pleij EA, Ribbert LS et al. Is 3D technique superior to 2D in Down syndrome screening? Evaluation of six second and third trimester fetal profile markers. Prenat Diagn 2014; Oct 23 DOI: 10.1002/pd.4521. [Epub ahead of print]
  • 30 Kagan KO, Hoopmann M, Hammer R et al. Screening auf Chromosomenstörungen mittels Ersttrimester-Screening und non-invasive prenatal Testing. Ultraschall Med 2015; 36: 40-46